Meeting Healthcare Needs of Border Residents  

Translate to Spanish or other 102 languages!

Dr. Karina Madrigal, EdD, MA, assistant professor of Pediatrics and director of Faculty Development, UTRGV School of Medicine. (UTRGV Photo by Jennifer Galindo) BGD: UTRGV Image
Dr. Karina Madrigal, EdD, MA, assistant professor of Pediatrics and director of Faculty Development, UTRGV School of Medicine. (UTRGV Photo by Jennifer Galindo) BGD: UTRGV Image

Mega Doctor News

- Advertisement -
By Saira Cabrera  

RIO GRANDE VALLEY, Texas – The UTRGV School of Medicine has been awarded a grant to help meet the healthcare needs of Hispanic communities on the South Texas border.   The $5,000 grant from The University of Texas Kenneth I. Shine Academy of Health Science Education is for a nine-month certificate pilot program – “Better Teachers, Better Healthcare for Historically Underserved Hispanics at the Border: MedEd Teaching Certificate Program” – meant to focus on innovative medical education and best teaching practices.  Because the program is tailored to the border’s specific healthcare needs, medical educators will gain professional development opportunities as clinical faculty members to enhance student learning and, in turn, produce physicians better trained to meet the healthcare needs of historically underserved Hispanics at the Border.  

Dr. Karina Madrigal, EdD, MA, assistant professor of Pediatrics and director of Faculty Development, is principal investigator on the grant.  

“We will be able to increase our current efforts to train the next generation of physicians in using modern medical education and innovative teaching strategies in both the classroom and clinical setting,” Madrigal said. “These efforts are significant to me because I am a Valley native, and I believe we can further prepare our students to better care for our underserved communities.”  

The end goal, Madrigal said, is to enhance the patient experience in medically underserved communities like the Valley.  

- Advertisement -

The team’s goals include:  

• Implementing active learning techniques and technology. 

• Strategically developing educational innovations.   

• Incorporating evidence-based medical education strategies.

- Advertisement -

The team also aims to establish an educational philosophy anchored in Hispanic border healthcare needs by recognizing the unique social determinants of health, cultural awareness, and cultural competency.

In addition to Madrigal, the team of co-investigators includes:  

Dr. Beatriz Tapia, MD, EdD, MPH, interim associate dean of Faculty Affairs and Development, assistant dean for Pediatrics and associate professor of Pediatrics.  

Dr. Robert Nelson Jr., MD, MS, FAAP, interim vice dean for Educational Affairs, senior associate dean of Faculty Affairs and chair of Pediatrics.  

Dr. Rene Corbeil, EdD, professor in the UTRGV Department of Teaching and Learning, Educational Technology, served as a technology consultant. 

The grant helps reinforce the UTRGV MedEd Teaching Certificate Program launched in November 2021.  

Founded in 2005, the Shine Academy was created to serve The University of Texas System through the support and advancement of excellence in health science education, educational scholarship, and leadership.  

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Beat the Summer Heat: Essential Hydration Tips

Summer heat has a way of sneaking up on you, making it easy to become dehydrated before you even realize you're thirsty.

STHS’ Transform Your Life Event Inspires Healthier Living Across the RGV

Whether you're making healthier food choices, becoming more active or focusing on your mental well-being, every positive change can help you live a longer, healthier and more fulfilling life.

STHS Dedicating Latest “South Texas Healthy Living” Episode to Arthritis Education, July 26th

More than 58 million U.S. adults are living with doctor-diagnosed arthritis, according to the Centers for Disease Control and Prevention (CDC), making it the nation’s leading cause of disability.

No More Needles: FDA Approves First Daily Pill to Replace Injectable Cholesterol Drugs

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.
- Advertisement -